Jing Rao
Key Laboratory Of Preclinical Study For New Drugs Of Gansu Province, 2019RU066
Lanzhou, 730000, China
Lanzhou, 730000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Novel Feleucin-K3-Derived Peptides Modified with Sulfono-γ-AA Building Blocks Targeting Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus Infections.
Journal: Journal of medicinal chemistry
Published: November 09, 2022
Potent Antimicrobial and Antibiofilm Activities of Feleucin-K3 Analogs Modified by α-(4-Pentenyl)-Ala against Multidrug-Resistant Bacteria.
Journal: Biomolecules
Published: April 24, 2021
Feleucin-K3 Analogue with an α-(4-Pentenyl)-Ala Substitution at the Key Site Has More Potent Antimicrobial and Antibiofilm Activities in Vitro and in Vivo.
Journal: ACS infectious diseases
Published: December 09, 2020
1,3-Dipolar Cycloaddition between Dehydroalanines and C,N-Cyclic Azomethine Imines: Application to Late-Stage Peptide Modification.
Journal: Angewandte Chemie (International ed. in English)
Published: September 14, 2020
The antimicrobial peptide YD attenuates inflammation via miR-155 targeting CASP12 during liver fibrosis.
Journal: Acta pharmaceutica Sinica. B
Published: May 20, 2020
Protective effect of peptide DR8 on bleomycin-induced pulmonary fibrosis by regulating the TGF-β/MAPK signaling pathway and oxidative stress.
Journal: Toxicology and applied pharmacology
Published: June 03, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026